Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2018 Filed Apr 9, 2018 21:55 UTC |
Freire Maria CDirector
|
GrantOption (right to buy) · Derivative | 28,240 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0000939767-18-000049 · wf-form4_152331090999767.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,240 Underlying: Common Stock · 28,240 shares Expires 2025-04-04 F4 · derivative.exercise_date: The option was granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date, subject to the Reporting Peron's continuous service through such date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 21:55 UTC |
Freire Maria CDirector
|
GrantCommon Stock | 14,120 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000049 · wf-form4_152331090999767.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the first four anniversaries of the Transaction Date, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 14,120 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC |
MARCHESI VINCENT TDirector
|
SaleCommon Stock | 15,000 | $24.73 | $370,950.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,913 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.53 to $25.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:26 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000040 · wf-form4_152046875776642.xml · derivative · entry 3 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:26 UTC |
FELDBAUM CARL BDirector
|
SaleCommon Stock | 11,000 | $23.88 | $262,680.00 |
DisclosureSEC source: 0000939767-18-000040 · wf-form4_152046875776642.xml · nonDerivative · entry 2 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,733 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.86 to $23.98. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:26 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionCommon Stock | 11,000 | $11.66 | $128,260.00 |
DisclosureSEC source: 0000939767-18-000040 · wf-form4_152046875776642.xml · nonDerivative · entry 1 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC |
COHEN CHARLESDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC |
COHEN CHARLESDirector
|
SaleCommon Stock | 15,000 | $24.23 | $363,450.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.15 to $24.39. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC |
COHEN CHARLESDirector
|
Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:03 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000033 · wf-form4_152003896142652.xml · derivative · entry 3 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:03 UTC |
PAPADOPOULOS STELIOSDirector
|
SaleCommon Stock | 15,000 | $24.05 | $360,750.00 |
DisclosureSEC source: 0000939767-18-000033 · wf-form4_152003896142652.xml · nonDerivative · entry 2 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,314 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.02 to $24.09. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:03 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000033 · wf-form4_152003896142652.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · derivative · entry 5 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 18, 2011. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · derivative · entry 4 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC |
WILLSEY LANCEDirector
|
SaleCommon Stock | 30,000 | $23.91 | $717,300.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.86 to $23.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 3, 2018 01:04 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 7,293 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0000939767-18-000034 · wf-form4_152003903149839.xml · derivative · entry 3 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,293 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 7,293 shares of Exelixis, Inc. common stock, became fully exercisable on February 26, 2013. Read SEC document |
| March 01, 2018 Filed Mar 3, 2018 01:04 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 7,293 | $4.42 | $32,235.06 |
DisclosureSEC source: 0000939767-18-000034 · wf-form4_152003903149839.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 01:00 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 3,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000031 · wf-form4_152003878922288.xml · derivative · entry 7 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2018-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 3,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 01:00 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 10,625 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-18-000031 · wf-form4_152003878922288.xml · derivative · entry 6 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,375 Underlying: Common Stock · 10,625 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, was exercisable as to 40,625 shares as of the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of November 17, 2014 grant date. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 01:00 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 45,029 | $27.13 | $1,221,636.77 |
DisclosureSEC source: 0000939767-18-000031 · wf-form4_152003878922288.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,490 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.03 to $27.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 01:00 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 3,000 | $5.50 | $16,500.00 |
DisclosureSEC source: 0000939767-18-000031 · wf-form4_152003878922288.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 01:00 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 10,625 | $1.76 | $18,700.00 |
DisclosureSEC source: 0000939767-18-000031 · wf-form4_152003878922288.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:59 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000030 · wf-form4_152003872483676.xml · derivative · entry 3 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:59 UTC |
POSTE GEORGEDirector
|
SaleCommon Stock | 15,000 | $26.26 | $393,900.00 |
DisclosureSEC source: 0000939767-18-000030 · wf-form4_152003872483676.xml · nonDerivative · entry 2 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,398 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.05 to $26.63. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:59 UTC |
POSTE GEORGEDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000030 · wf-form4_152003872483676.xml · nonDerivative · entry 1 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
Exercise / conversionOption (right to buy) · Derivative | 11,500 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · derivative · entry 6 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Option (right to buy) · 11,500 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2009. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
SaleCommon Stock | 11,500 | $30.00 | $345,000.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · nonDerivative · entry 4 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,329 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2017. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
Exercise / conversionCommon Stock | 11,500 | $7.97 | $91,655.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · nonDerivative · entry 3 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
Exercise / conversionOption (right to buy) · Derivative | 3,500 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · derivative · entry 5 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Option (right to buy) · 3,500 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2009. Read SEC document |
| January 08, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
SaleCommon Stock | 3,500 | $31.29 | $109,515.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · nonDerivative · entry 2 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,329 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2017. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.51. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| January 08, 2018 Filed Jan 11, 2018 00:27 UTC |
Garber Alan MDirector
|
Exercise / conversionCommon Stock | 3,500 | $7.97 | $27,895.00 |
DisclosureSEC source: 0000939767-18-000002 · wf-form4_151563042764056.xml · nonDerivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2017 Filed Jan 20, 2018 01:21 UTC |
Hessekiel JeffreyEVP and General Counsel
|
GiftCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000005 · wf-form5_151641124605599.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,442 F1 · balance_after: Includes 62,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 04, 2017 Filed Jan 20, 2018 01:22 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000006 · wf-form5_151641130909874.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 169,698 F1 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| December 04, 2017 Filed Jan 20, 2018 01:22 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000006 · wf-form5_151641130909874.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 171,698 F1 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:47 UTC |
Lamb PeterEVP, Scientific Strategy & CSO
|
Tax withholdingCommon Stock | 2,204 | $24.75 | $54,549.00 |
DisclosureSEC source: 0000939767-17-000195 · wf-form4_151096605625450.xml · nonDerivative · entry 1 Lamb Peter · CIK 0001387306 · EVP, Scientific Strategy & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,396 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 22, 2016. F2 · balance_after: Includes 67,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:47 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Tax withholdingCommon Stock | 2,609 | $24.75 | $64,572.75 |
DisclosureSEC source: 0000939767-17-000194 · wf-form4_151096601230005.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,396 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. F2 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:46 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Tax withholdingCommon Stock | 244 | $24.75 | $6,039.00 |
DisclosureSEC source: 0000939767-17-000193 · wf-form4_151096596397336.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,175 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 30, 2013. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:46 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Tax withholdingCommon Stock | 1,290 | $24.75 | $31,927.50 |
DisclosureSEC source: 0000939767-17-000193 · wf-form4_151096596397336.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,419 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 18, 2013. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:46 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Tax withholdingCommon Stock | 2,205 | $24.75 | $54,573.75 |
DisclosureSEC source: 0000939767-17-000193 · wf-form4_151096596397336.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,709 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. F2 · balance_after: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:45 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Tax withholdingCommon Stock | 2,120 | $24.75 | $52,470.00 |
DisclosureSEC source: 0000939767-17-000192 · wf-form4_151096591636940.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,942 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. F2 · balance_after: Includes 62,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,116 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan on October 31, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:44 UTC |
Senner Christopher J.EVP and CFO
|
Tax withholdingCommon Stock | 2,762 | $24.75 | $68,359.50 |
DisclosureSEC source: 0000939767-17-000191 · wf-form4_151096586626612.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,497 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. F2 · balance_after: Includes 77,500 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:43 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 8,347 | $24.75 | $206,588.25 |
DisclosureSEC source: 0000939767-17-000190 · wf-form4_151096581980479.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,653 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. F2 · balance_after: Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 23:51 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0000939767-17-000172 · wf-form4_150724749988691.xml · derivative · entry 4 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2024-10-02 F5 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 23:51 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-17-000172 · wf-form4_150724749988691.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,914 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on November 15, 2018, and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each November 15th until fully-vested. F3 · balance_after: Includes 77,553 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,361 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan on April 28, 2017. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
GrantOption (right to buy) · Derivative | 150,000 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0000939767-17-000171 · wf-form4_150724744606566.xml · derivative · entry 3 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-10-02 F5 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-17-000171 · wf-form4_150724744606566.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,005 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on November 15, 2018, and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each November 15th until fully-vested. F3 · balance_after: Includes 95,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.